Cardiovascular Systems Stock
Price
Target price
-
-
-
-
-
-
WKN: A0RF8V / Symbol: CSII / Name: Cardiovascular / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Cardiovascular Systems in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cardiovascular Systems vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cardiovascular Systems | - | - | - | - | - | - | - |
| Orthofix Medical Inc. | 1.160% | 0.575% | -11.616% | -24.569% | -32.171% | -50.843% | -73.485% |
| Lantheus Holdings Inc | 0.340% | -0.114% | -5.400% | 90.435% | 53.147% | 39.048% | - |
| Natera Inc | -0.400% | 16.963% | 12.427% | 96.788% | 36.853% | 423.495% | 215.322% |
News
Heartflow Q2 Earnings Call Highlights
Key Points
- Interested in Heartflow, Inc.? Here are five stocks we like better.
- Strong second-quarter growth: Revenue rose 48% year over year to $64.1 million, while global case volume increased
HLS Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in HLS Therapeutics Inc.? Here are five stocks we like better.
- Q2 revenue rose 3.5% to $14.7 million, while adjusted EBITDA declined to $4.7 million due to NILEMDO launch
Cardiol Therapeutics Advances CardiolRx in Pivotal Phase III Pericarditis Trial
Key Points
- Interested in Cardiol Therapeutics Inc.? Here are five stocks we like better.
- Cardiol Therapeutics is advancing CardiolRx into the pivotal Phase III MAVERIC trial for preventing